A PHASE 1, RANDOMIZED, SINGLE-BLIND, PLACEBO-CONTROLLED PHARMACOKINETIC STUDY EVALUATING ORAL BX002-A BACTERIOPHAGE THERAPY FOR INFLAMMATORY BOWEL DISEASE

Urania Rappo  1     Ariel Cohen  2     Edith Kario  2     Merav Bassan  2     Sailaja Puttagunta  2    
1 BiomX, Inc., Branford, United States
2 BiomX, Ltd., Ness Ziona, Israel

Topic
Gut Microbiota, IBD, Immunology

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing